Compare LACTOSE INDIA with KREBS BIOCHEMICALS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs KREBS BIOCHEMICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA KREBS BIOCHEMICALS LACTOSE INDIA/
KREBS BIOCHEMICALS
 
P/E (TTM) x -81.2 -10.3 - View Chart
P/BV x 1.3 - - View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LACTOSE INDIA   KREBS BIOCHEMICALS
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
KREBS BIOCHEMICALS
Mar-21
LACTOSE INDIA/
KREBS BIOCHEMICALS
5-Yr Chart
Click to enlarge
High Rs42148 28.3%   
Low Rs1660 26.6%   
Sales per share (Unadj.) Rs30.627.4 111.7%  
Earnings per share (Unadj.) Rs-2.2-14.5 15.0%  
Cash flow per share (Unadj.) Rs1.6-11.8 -13.9%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs30.1-23.9 -126.1%  
Shares outstanding (eoy) m11.4419.62 58.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.93.8 24.9%   
Avg P/E ratio x-13.3-7.2 185.4%  
P/CF ratio (eoy) x17.6-8.8 -200.2%  
Price / Book Value ratio x1.0-4.3 -22.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m3302,039 16.2%   
No. of employees `000NANA-   
Total wages/salary Rs m106153 69.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m350537 65.1%  
Other income Rs m36 50.4%   
Total revenues Rs m353543 64.9%   
Gross profit Rs m62-176 -35.4%  
Depreciation Rs m4451 85.1%   
Interest Rs m5463 86.8%   
Profit before tax Rs m-33-284 11.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-80-   
Profit after tax Rs m-25-284 8.7%  
Gross profit margin %17.8-32.7 -54.4%  
Effective tax rate %24.20-   
Net profit margin %-7.1-52.8 13.4%  
BALANCE SHEET DATA
Current assets Rs m197214 92.0%   
Current liabilities Rs m116482 24.1%   
Net working cap to sales %23.1-49.9 -46.3%  
Current ratio x1.70.4 381.3%  
Inventory Days Days5954 109.4%  
Debtors Days Days67120 3,293.5%  
Net fixed assets Rs m6861,378 49.8%   
Share capital Rs m114196 58.3%   
"Free" reserves Rs m230-665 -34.6%   
Net worth Rs m345-469 -73.5%   
Long term debt Rs m3931,005 39.1%   
Total assets Rs m8831,592 55.5%  
Interest coverage x0.4-3.5 -11.4%   
Debt to equity ratio x1.1-2.1 -53.1%  
Sales to assets ratio x0.40.3 117.3%   
Return on assets %3.4-13.9 -24.2%  
Return on equity %-7.260.5 -11.9%  
Return on capital %3.0-41.2 -7.2%  
Exports to sales %00-   
Imports to sales %7.40-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m26NA-   
Fx inflow Rs m250-   
Fx outflow Rs m2721 129.3%   
Net fx Rs m-2-21 10.1%   
CASH FLOW
From Operations Rs m22-146 -14.9%  
From Investments Rs m-62-225 27.4%  
From Financial Activity Rs m45377 12.0%  
Net Cashflow Rs m55 95.5%  

Share Holding

Indian Promoters % 49.1 72.7 67.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.7 0.0 6,800.0%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 50.9 27.3 186.6%  
Shareholders   15,737 8,571 183.6%  
Pledged promoter(s) holding % 47.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   SHREE GANESH REMEDIES   PFIZER  JUBILANT INGREVIA  SUVEN LIFE SCIENCES  PANACEA BIOTECH  



Today's Market

FabIndia IPO, Tanla Platforms' Partnership with Vodafone Idea, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a strong note yesterday. Benchmark indices snapped two days of losses and witnessed sharp gains as globally fears of a significant impact on economic.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

The Biggest Winners and Losers in India's Transition to Electric Vehicles(Profit Hunter)

Nov 26, 2021

How India's EV transition could be a major headwind for the incumbents.

7 Stocks that Mutual Funds Can't get Enough of(Views On News)

Dec 1, 2021

Come hell or high water, these are the top Indian stocks which mutual funds never leave.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Dec 7, 2021 (Close)

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA - NATURAL CAPS COMPARISON

COMPARE LACTOSE INDIA WITH

MARKET STATS